Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Sexually Transmitted Diseases (STDs) are diseases that spread primarily through person-to-person sexual contact. Early identification or diagnosis of STDs and partner notification can help halt further transmission.

Statistics:

The global diagnostic testing of STDs market is estimated to account for US$ 290,128.2 Mn in terms of value by the end of 2027.

Global Diagnostic Testing of STDs Market: Drivers

Increasing prevalence of STDs is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. For instance, according to UNAIDS Global HIV & AIDS statistics — 2019 fact sheet, 37.9 million people were infected with HIV worldwide.

Moreover, increasing funding to treatment and management of STDs is also expected to aid in growth of the market. For instance, in February 2020, the U.S. government released its Fiscal Year 2021 Federal Budget proposal that includes US$ 716 million for the second year of the multiyear Ending the HIV Epidemic: A Plan for America (EHE) initiative to eliminate HIV in America.

Statistics:

Asia Pacific held dominant position in the global diagnostic testing of STDs market in 2019, accounting for 36.3% share in terms of value, followed by North America and Europe, respectively

Figure 1: Global Diagnostic Testing of STDs Market Share (%) Value, By Region, 2019

Diagnostic Testing of STDs  | Coherent Market Insights

Global Diagnostic Testing of STDs Market: Restraints 

Stigma associated with voluntary / Client-Initiated Counselling and Testing (CICT) STD testing is expected to hinder growth of the market. Many refrain from voluntary / CICT STD testing at any of the labs or STD clinics to avoid uncomfortable situations or embarrassment in the society. This hinders the uptake of diagnostic tests or testing volume, thus restraining growth of the market.

Moreover, stringent regulatory scenario is also expected to limit the market growth. In Europe, diagnostic testing devices for STDs can be commercialized with a CE mark that can be obtained through compliance to the Directive of ‘In Vitro Diagnostic Medical Devices, 98/79/EC’ and CLIA waivers. Other countries accept the U.S. FDA approval or CE Mark.

request-sample

Diagnostic Testing of STDs Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 140,028.5 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 9.6% 2027 Value Projection: US$ 290,128.2 Mn
Geographies covered (27):
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • Test Type: Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, Chancroid
Companies covered:

Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.

Growth Drivers:
  • Increasing prevalence of STDs
  • Increasing funding to treatment and management of STDs
Restraints & Challenges:
  • Social stigma associated with testing
  • Stringent regulation

Global Diagnostic Testing of STDs Market: Opportunities   

R&D in HIV self-testing kits is expected to offer lucrative growth opportunities for players in the global diagnostic testing of STDs market. For instance, in August 2019, researchers at the Center for Urban Health Solutions at St. Michael's Hospital, Canada, started clinical trial on HIV self-testing kits with the aim of gaining federal approval for the first such device in Canada.

Moreover, increase in sexually transmitted infections is also expected to aid in growth of the market. For instance, there were over 126,700 chlamydia infections and 28,300 cases of gonorrhea diagnosed in 2017 in Canada, according to provincial and territorial government data compiled in 2019.

Statistics:

The global diagnostic testing of STDs market was valued at US$ 140,028.5 Mn in 2019 and is forecast to reach a value of US$ 290,128.2 Mn by 2027 at a CAGR of 9.6% between 2020 and 2027.

Figure 2: Global Diagnostic Testing of STDs Market Value (US$ Mn), 2016 – 2027

Diagnostic Testing of STDs  | Coherent Market Insights

Market Trends/Key Takeaways

The market in Canada is witnessing sale of unlicensed test kits majorly through online distribution channels. Clinical trials to boost device approvals are necessary to address the issue.

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in November 2019, Chembio Diagnostics received World Health Organization approval for its Sure Check HIV Self-Test, a single-use immunochromatographic test for the detection of antibodies to HIV types 1 and 2.

Global Diagnostic Testing of STDs Market: Competitive Landscape

Major players operating in the global diagnostic testing of STDs market include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.

Global Diagnostic Testing of STDs Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2020, binx health received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its binx io, a molecular point-of-care testing platform for the detection of chlamydia and gonorrhea.

Major players in the market are also focused on adopting collaboration strategies to expand their product portfolio. For instance, in February 2020, Pinpoint Science Inc. collaborated with Analog Devices, Inc. to advance the development and manufacture of novel nanosensor diagnostics for infectious diseases.

Diagnostic Testing of STDs are used for identification and diagnosis of sexually transmitted diseases. These diseases are transmitted through person-to-person sexual contact. Approval and launch of new diagnostic tests is expected to propel growth of the global diagnostic testing of STDs market over the forecast period. Moreover, increasing incidence of STDs in developing and developed economies along with increasing awareness is also expected to drive the market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Diagnostic Testing of STDs market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Diagnostic Testing of STDs market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Diagnostic Testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Diagnostic Testing of STDs market

Detailed Segmentation:

  • Global Diagnostic Testing of STDs Market, By Test Type:
    • Chlamydia
    • Gonorrhea
    • Syphilis
    • HIV
    • HPV+pap smear
    • HSV
    • Chancroid
  • Global Diagnostic Testing of STDs Market, By Region:
    • North America
      • By Test Type:
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • HIV
        • HPV+pap smear
        • HSV
        • Chancroid
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Test Type:
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • HIV
        • HPV+pap smear
        • HSV
        • Chancroid
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type:
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • HIV
        • HPV+pap smear
        • HSV
        • Chancroid
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • HIV
        • HPV+pap smear
        • HSV
        • Chancroid
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type:
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • HIV
        • HPV+pap smear
        • HSV
        • Chancroid
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • HIV
        • HPV+pap smear
        • HSV
        • Chancroid
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Vela Diagnostics USA Inc. *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Roche Holdings AG
    • Alere, Inc.
    • Becton Dickinson & Company
    • bioMerieux
    • Danaher Corporation (Beckman Coulter)
    • Hologic, Inc.
    • binx health
    • Chembio Diagnostics
    • Pinpoint Science Inc.
    • bioLytical Laboratories
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Diagnostic Testing of STDs Market, By Test Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Chlamydia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gonorrhea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Syphilis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • HIV
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • HPV+pap smear
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • HSV
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chancroid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Diagnostic Testing of STDs Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  6. Competitive Landscape
    • Company Profiles
      • Vela Diagnostics USA Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Roche Holdings AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Alere, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton Dickinson & Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • bioMerieux
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Danaher Corporation (Beckman Coulter)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hologic, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • binx health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Chembio Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pinpoint Science Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • bioLytical Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Diagnostic Testing of STDs Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Diagnostic Testing of STDs market size was valued at US$ 140,028.5 million in 2019 and is estimated to exhibit a CAGR of 9.6% between 2020 and 2027.
Chlamydia segment held the major market share in 2019 owing to an Increasing prevalence of chlamydia is expected to propel growth of the global diagnostic testing of STDs market over the forecast period.
Major factor driving the growth of Global Diagnostic Testing of STDs market during the forecast period increasing prevalence of STDs is expected to propel growth of the global diagnostic testing of STDs market over the forecast period.
Major factors hampering the growth of the Global Diagnostic Testing of STDs market during the forecast period constitutes of contamination of social stigma for testing and stringent regulatory scenario is also expected to limit the market growth.
Asia Pacific market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner